OMNIlife science Closes $27.5M Debt Financing

OMNIlife science, Inc., an East Taunton, MA-based medical technology company, closed a $27.5m debt financing.

The debt facility is being provided by affiliates of Deerfield Management Company.

The company plans to use the proceeds to continue to expand its hip and knee replacement implant product lines and to complete commercial development of its proprietary FDA cleared OMNInav hip replacement solution.

Led by President and CEO George Cipolletti, OMNI is an established hip and knee implant replacement engineering, manufacturing and distribution company that has also developed a Robotics and Navigation platform, called OMNInav™, which uses a proprietary computer-assisted robotic cutting guide technology called OMNIplasty™.



Join the discussion